Henry Schein, Inc.  

(Public, NASDAQ:HSIC)   Watch this stock  
Find more results for HSIC
140.59
-2.15 (-1.51%)
Jan 28 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 140.25 - 143.74
52 week 109.34 - 143.89
Open 143.00
Vol / Avg. 476,132.00/416,679.00
Mkt cap 11.96B
P/E 26.49
Div/yield     -
EPS 5.31
Shares 84.21M
Beta 0.84
Inst. own 94%
Feb 11, 2015
Q4 2014 Henry Schein Inc Earnings Call - 10:00AM EST - Add to calendar
Feb 11, 2015
Q4 2014 Henry Schein Inc Earnings Release - 9:30AM EST - Add to calendar
Jan 13, 2015
Henry Schein Inc at JPMorgan Healthcare Conference
Dec 2, 2014
Henry Schein Inc at Piper Jaffray Healthcare Conference
Dec 2, 2014
Henry Schein Inc at NASDAQ OMX Investor Program - Webcast
Nov 19, 2014
Henry Schein Inc at Jefferies Global Healthcare Conference - London
Nov 18, 2014
Henry Schein Inc at Stifel Healthcare Conference
Nov 11, 2014
Henry Schein Inc at Credit Suisse Healthcare Conference
Nov 6, 2014
Q3 2014 Henry Schein Inc Earnings Call - Webcast
Nov 6, 2014
Q3 2014 Henry Schein Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 4.55% 4.96%
Operating margin 6.64% 7.08%
EBITD margin - 8.42%
Return on average assets 7.91% 8.65%
Return on average equity 16.24% 15.99%
Employees 16,000 -
CDP Score - -

Address

135 Duryea Road
MELVILLE, NY 11747
United States - Map
+1-631-8435500 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Henry Schein Inc. provides health care products and services to office-based dental, animal health and medical practitioners. The Company serves customers, including dental practitioners and laboratories, animal health clinics and physician practices, as well as government, institutional health care clinics and other alternate care clinics. It provides animal health, dental and medical products. The Company operates in countries including the United States, Australia, Austria, Belgium, Canada, China, the Czech Republic, France, Germany, Hong Kong SAR, Iceland, Ireland, Israel, Italy, Luxembourg, Mauritius, the Netherlands, New Zealand, Portugal, Slovakia, South Africa, Spain, Switzerland, Thailand and the United Kingdom. It offers a selection of products and services and value-added solutions for operating efficient practices and delivering high quality care. It conducts business through two segments: health care distribution and technology and value-added services.

Officers and directors

Stanley M. Bergman Chairman of the Board, Chief Executive Officer
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
James P. Breslawski CPA President, Chief Operating Officer, Director; Chief Executive Officer of Henry Schein Global Dental Group
Age: 60
Bio & Compensation  - Reuters
Steven Paladino CPA Chief Financial Officer, Executive Vice President, Director
Age: 57
Bio & Compensation  - Reuters
David McKinley President, Medical Group
Age: 61
Bio & Compensation  - Reuters
Bob Minowitz President, International Dental Group
Age: 55
Bio & Compensation  - Reuters
Lonnie Shoff President and Chief Executive Officer of Global Animal Health and Strategic Partnerships Group
Age: 55
Bio & Compensation  - Reuters
Gerald A. Benjamin Chief Administrative Officer, Executive Vice President, Director
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark E. Mlotek Chief Strategic Officer, Executive Vice President, Director
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
James A. Harding Chief Technology Officer, Senior Vice President
Age: 58
Bio & Compensation  - Reuters
Leonard A. David Chief Compliance Officer, Senior Vice President
Age: 65
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance